A new standard of care for infection control

Our Mission

To bring technology to patients to reduce catheter derived sepsis, save lives and reduce healthcare costs.


News

May 13, 2017


Great Lakes Pharmaceuticals, Inc. officially rebranded as Prevacept Infection Control, Inc. on May 13, 2017, in conjunction with rebranding of B-Lock Solution as PrevaCept Lock Solution.

August 2, 2017


Prevacept Infection Control, Inc. filed for CE-Mark for PrevaCept Lock Solution on August 2, 2017.

September 12, 2017


Prevacept closed the second tranche of an institutional financing on September 12, 2017